nodes	percent_of_prediction	percent_of_DWPC	metapath
Tyloxapol—LPL—blood vessel—brain cancer	0.147	0.172	CbGeAlD
Tyloxapol—LPL—hindbrain—brain cancer	0.14	0.164	CbGeAlD
Tyloxapol—LPL—brainstem—brain cancer	0.0804	0.0939	CbGeAlD
Tyloxapol—LPL—telencephalon—brain cancer	0.0713	0.0833	CbGeAlD
Tyloxapol—LPL—pituitary gland—brain cancer	0.0581	0.0678	CbGeAlD
Tyloxapol—LPL—medulla oblongata—brain cancer	0.0561	0.0655	CbGeAlD
Tyloxapol—LPL—midbrain—brain cancer	0.0512	0.0598	CbGeAlD
Tyloxapol—LPL—spinal cord—brain cancer	0.05	0.0584	CbGeAlD
Tyloxapol—LPL—endocrine gland—brain cancer	0.045	0.0526	CbGeAlD
Tyloxapol—LPL—head—brain cancer	0.0444	0.0519	CbGeAlD
Tyloxapol—LPL—central nervous system—brain cancer	0.0406	0.0474	CbGeAlD
Tyloxapol—LPL—cerebellum—brain cancer	0.0396	0.0463	CbGeAlD
Tyloxapol—LPL—brain—brain cancer	0.0322	0.0376	CbGeAlD
Tyloxapol—LPL—SREBP signalling—SIRT1—brain cancer	0.00964	0.0671	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—RELA—brain cancer	0.00742	0.0516	CbGpPWpGaD
Tyloxapol—LPL—Transcriptional regulation of white adipocyte differentiation—CDK4—brain cancer	0.00668	0.0465	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	0.00568	0.0395	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—MYC—brain cancer	0.00522	0.0364	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—EGFR—brain cancer	0.00511	0.0356	CbGpPWpGaD
Tyloxapol—LPL—Transcriptional regulation of white adipocyte differentiation—RELA—brain cancer	0.00491	0.0342	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.00479	0.0333	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—IRS2—brain cancer	0.00468	0.0326	CbGpPWpGaD
Tyloxapol—LPL—Disease—DTX2—brain cancer	0.00377	0.0262	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.0035	0.0244	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—OR4C12—brain cancer	0.0031	0.0216	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—OR14C36—brain cancer	0.0031	0.0216	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—TRPC6—brain cancer	0.00299	0.0208	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—CTNNB1—brain cancer	0.00281	0.0196	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—TP53—brain cancer	0.00278	0.0194	CbGpPWpGaD
Tyloxapol—LPL—Disease—HES5—brain cancer	0.00277	0.0193	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—DTX2—brain cancer	0.00264	0.0184	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—STAT3—brain cancer	0.00245	0.017	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CYP2C9—brain cancer	0.00213	0.0148	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PTCH2—brain cancer	0.002	0.0139	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HES5—brain cancer	0.00194	0.0135	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—HES1—brain cancer	0.00193	0.0134	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—STRADA—brain cancer	0.00188	0.0131	CbGpPWpGaD
Tyloxapol—LPL—Disease—IDH1—brain cancer	0.00186	0.013	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—BSG—brain cancer	0.00181	0.0126	CbGpPWpGaD
Tyloxapol—LPL—Disease—HEY1—brain cancer	0.00176	0.0123	CbGpPWpGaD
Tyloxapol—LPL—Disease—DLL1—brain cancer	0.00173	0.012	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ABR—brain cancer	0.00157	0.0109	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—IDH1—brain cancer	0.00156	0.0109	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GLI2—brain cancer	0.00152	0.0106	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—CDK4—brain cancer	0.00151	0.0105	CbGpPWpGaD
Tyloxapol—LPL—Disease—SHH—brain cancer	0.00147	0.0102	CbGpPWpGaD
Tyloxapol—LPL—Disease—ENO2—brain cancer	0.00147	0.0102	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GLI1—brain cancer	0.00143	0.00992	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SUFU—brain cancer	0.00135	0.0094	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—GFAP—brain cancer	0.0013	0.00907	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.00127	0.00883	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HEY1—brain cancer	0.00124	0.0086	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ENO2—brain cancer	0.00123	0.00858	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—DLL1—brain cancer	0.00121	0.00843	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—RELA—brain cancer	0.00111	0.00773	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—ERBB2—brain cancer	0.0011	0.00768	CbGpPWpGaD
Tyloxapol—LPL—Disease—VAV1—brain cancer	0.00106	0.0074	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SHH—brain cancer	0.00103	0.00717	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TRPC6—brain cancer	0.000994	0.00692	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PTCH1—brain cancer	0.000977	0.0068	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SMO—brain cancer	0.000977	0.0068	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—CTNNB1—brain cancer	0.000966	0.00672	CbGpPWpGaD
Tyloxapol—LPL—Disease—HES1—brain cancer	0.000914	0.00636	CbGpPWpGaD
Tyloxapol—LPL—Disease—PDGFRA—brain cancer	0.000871	0.00606	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—VEGFA—brain cancer	0.00085	0.00592	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—STAT3—brain cancer	0.000842	0.00586	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NOTCH2—brain cancer	0.000781	0.00544	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—EGFR—brain cancer	0.000765	0.00532	CbGpPWpGaD
Tyloxapol—LPL—Disease—IRS2—brain cancer	0.000764	0.00532	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—VAV1—brain cancer	0.000744	0.00518	CbGpPWpGaD
Tyloxapol—LPL—Disease—APC—brain cancer	0.000675	0.0047	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HES1—brain cancer	0.00064	0.00446	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PDGFRA—brain cancer	0.00061	0.00424	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SPP1—brain cancer	0.000592	0.00412	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PIK3CG—brain cancer	0.000565	0.00393	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IRS2—brain cancer	0.000535	0.00373	CbGpPWpGaD
Tyloxapol—LPL—Disease—ERBB2—brain cancer	0.000524	0.00365	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—APC—brain cancer	0.000473	0.00329	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PIK3CG—brain cancer	0.000473	0.00329	CbGpPWpGaD
Tyloxapol—LPL—Disease—CTNNB1—brain cancer	0.000459	0.00319	CbGpPWpGaD
Tyloxapol—LPL—Disease—STAT3—brain cancer	0.0004	0.00278	CbGpPWpGaD
Tyloxapol—LPL—Disease—MYC—brain cancer	0.000371	0.00259	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—RELA—brain cancer	0.000369	0.00257	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—ERBB2—brain cancer	0.000367	0.00255	CbGpPWpGaD
Tyloxapol—LPL—Disease—EGFR—brain cancer	0.000363	0.00253	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—IL2—brain cancer	0.000333	0.00232	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CCND1—brain cancer	0.000324	0.00226	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CTNNB1—brain cancer	0.000321	0.00223	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—VEGFA—brain cancer	0.000283	0.00197	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—STAT3—brain cancer	0.00028	0.00195	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MYC—brain cancer	0.00026	0.00181	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—EGFR—brain cancer	0.000254	0.00177	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TP53—brain cancer	0.000214	0.00149	CbGpPWpGaD
